Literature DB >> 10428759

Substitution of the insulin receptor transmembrane domain with that of glycophorin A inhibits insulin action.

A Gardin1, C Auzan, E Clauser, T Malherbe, D Aunis, G Crémel, P Hubert.   

Abstract

To study the role of transmembrane (TM) domains interactions in the activation of the insulin receptor, we have replaced the insulin receptor TM domain with that of glycophorin A (GpA), an erythrocyte protein that spontaneously forms detergent-resistant dimers through TM-TM interactions. Insulin receptor cDNA sequences with the TM domain replaced by that of GpA were constructed and stably transfected in CHO cells. Insulin binding to cells and solubilized receptors was not modified. Electrophoresis after partial reduction of disulfide bonds revealed an altered structure for the soluble chimeric receptors, seen as an altered mobility apparently due to increased interactions between the beta subunits of the receptor. Insulin signaling was markedly decreased for cells transfected with chimeric receptors compared with cells transfected with normal receptors. A decrease in insulin-induced receptor kinase activity was observed for solubilized chimeric receptors. In conclusion, substitution by the native GpA TM domain of the insulin receptor results in structurally modified chimeric receptors that are unable to transmit the insulin signal properly. It is hypothesized that this substitution may impose structural constraints that prevent the proper changes in conformation necessary for activation of the receptor kinase. Other mutants modifying the structure or the membrane orientation of the glycophorin A TM domain are required to better understand these constraints.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428759     DOI: 10.1096/fasebj.13.11.1347

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  9 in total

Review 1.  Single-spanning transmembrane domains in cell growth and cell-cell interactions: More than meets the eye?

Authors:  Pierre Hubert; Paul Sawma; Jean-Pierre Duneau; Jonathan Khao; Jérôme Hénin; Dominique Bagnard; James Sturgis
Journal:  Cell Adh Migr       Date:  2010-04-20       Impact factor: 3.405

Review 2.  Role of receptor tyrosine kinase transmembrane domains in cell signaling and human pathologies.

Authors:  Edwin Li; Kalina Hristova
Journal:  Biochemistry       Date:  2006-05-23       Impact factor: 3.162

3.  Insulin receptor activation with transmembrane domain ligands.

Authors:  Jongsoon Lee; Masaya Miyazaki; Giulio R Romeo; Steven E Shoelson
Journal:  J Biol Chem       Date:  2014-05-27       Impact factor: 5.157

4.  Hormone-triggered conformational changes within the insulin-receptor ectodomain: requirement for transmembrane anchors.

Authors:  R R Flörke; K Schnaith; W Passlack; M Wichert; L Kuehn; M Fabry; M Federwisch; H Reinauer
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

5.  Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain.

Authors:  S N Constantinescu; T Keren; M Socolovsky; H Nam ; Y I Henis; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

6.  Transmembrane peptides as inhibitors of ErbB receptor signaling.

Authors:  Amar Bennasroune; Maria Fickova; Anne Gardin; Sylvie Dirrig-Grosch; Dominique Aunis; Gérard Crémel; Pierre Hubert
Journal:  Mol Biol Cell       Date:  2004-05-14       Impact factor: 4.138

7.  Domain-dependent effects of insulin and IGF-1 receptors on signalling and gene expression.

Authors:  Weikang Cai; Masaji Sakaguchi; Andre Kleinridders; Gonzalo Gonzalez-Del Pino; Jonathan M Dreyfuss; Brian T O'Neill; Alfred K Ramirez; Hui Pan; Jonathon N Winnay; Jeremie Boucher; Michael J Eck; C Ronald Kahn
Journal:  Nat Commun       Date:  2017-03-27       Impact factor: 14.919

Review 8.  Transmembrane Peptides as Inhibitors of Protein-Protein Interactions: An Efficient Strategy to Target Cancer Cells?

Authors:  Camille Albrecht; Aline Appert-Collin; Dominique Bagnard; Sébastien Blaise; Béatrice Romier-Crouzet; Roman G Efremov; Hervé Sartelet; Laurent Duca; Pascal Maurice; Amar Bennasroune
Journal:  Front Oncol       Date:  2020-04-15       Impact factor: 6.244

9.  All-Atom Structural Models of the Transmembrane Domains of Insulin and Type 1 Insulin-Like Growth Factor Receptors.

Authors:  Hossein Mohammadiarani; Harish Vashisth
Journal:  Front Endocrinol (Lausanne)       Date:  2016-06-20       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.